Chertow et al identified factors associated with mortality in critically-ill patients who develop acute tubular necrosis (ATN). These can help to identify a patient who may benefit from more aggressive management. The authors are from Brigham and Women's Hospital, Cleveland Clinic Foundation, Stanford University, Scios, Inc., and the Auriculin Anaritide Acute Renal Failure Study Group.
